Chewing gum against viruses: revolutionary weapon in the fight against flu!

Chewing gum against viruses: revolutionary weapon in the fight against flu!

In a groundbreaking development, researchers of University of Pennsylvania An antiviral chewing gum, which is supposed to act specifically against flippation and herpes viruses. This innovative solution, which was originally designed during the Covid 19 pandemic, aims to neutralize viruses in the mouth and throat and thus stop the oral transmission of infections.

The chewing gum contains special plant cells and the protein CTB-A2, which binds to the coronavirus and can reduce the virus load in the mouth by up to 95 percent. The promising test results show that chewing gum works not only against Sars-Cov-2, but also against influenza-a tribes such as H1N1 and H3N2 as well as herpes simplex virus (HSV-1 and HSV-2). In laboratory tests, the product has proven to be as effective as the chewing gum against the Coronavirus, which nourishes hope for a broad use.

new developments and ingredients

In addition to the previous recipes, the researchers are working on new variants of the chewing gum, which contain label beans (Lablab Purpureus). These beans are known for their antiviral properties, which not only can neutralize certain herpes simplex viruses, but also influenza-a viruses. In tests, 40 milligrams of the bean flour have already reduced virus load by more than 95 percent, which speaks for effective application. This chewing gum releases the ingredients directly in the mouth, where the virus tends to get into the body, such as the Apotheke adhoc

In addition, the research team plans to use the powder contained in the beans to combat bird flu (H5N1). This virus variety is currently a threat, since over 54 million birds have been infected in North America and there have been several human infections in the USA and Canada. The bean powder has already proven to be effective against H5N1 and H7N9 in previous studies.

outlook on clinical studies

The team led by Professor Henry Daniell has not been able to carry out any clinical studies on humans, since the new chewing gum are in the preclinical phase. However, the researchers have indicated that the results of the laboratory examinations indicate a promising effect that could ensure cost -effective and easily accessible protection for broad population groups. The need for effective antiviral measures is reinforced by the current outbreaks of bird flu and seasonal influenza, so that the next phase of research will be decisive in order to prove the effectiveness of the chewing gum, as the page Research and knowledge.

The insights from this work could not only contribute to combating influenza and herpes, but also close an important gap in the health system by offering a new approach to fighting virus. Research is promising, but the final use of the chewing gum remains to be seen, while further tests have to be carried out in both laboratories and clinically.